ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

APLT Applied Therapeutics Inc

4,76
0,23 (5,08%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Applied Therapeutics Inc APLT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,23 5,08% 4,76 06:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,63 4,605 4,86 4,76 4,53
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.4.202413:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04.4.202413:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28.3.202421:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11.3.202413:17EDGAR2Form 8-K - Current report
06.3.202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06.3.202413:12EDGAR2Form 8-K - Current report
06.3.202413:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05.3.202423:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29.2.202422:18EDGAR2Form 8-K - Current report
28.2.202414:05GLOBEApplied Therapeutics Announces $100 Million Private..
28.2.202414:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22.2.202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15.2.202413:07EDGAR2Form 8-K - Current report
15.2.202413:00GLOBEApplied Therapeutics Announces Positive Results from..
15.2.202403:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.1.202423:02EDGAR2Form 8-K - Current report
04.1.202422:05GLOBEApplied Therapeutics Announces Topline Results from the..
03.1.202417:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03.1.202415:15EDGAR2Form 8-K - Current report
03.1.202413:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29.12.202322:23EDGAR2Form 8-K - Current report
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.12.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:11EDGAR2Form 8-K - Current report
13.11.202323:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09.11.202313:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202313:36EDGAR2Form 8-K - Current report
09.11.202313:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03.11.202321:37EDGAR2Form 144 - Report of proposed sale of securities
02.11.202321:33EDGAR2Form 144 - Report of proposed sale of securities
02.11.202312:00GLOBEApplied Therapeutics to Present at the UBS Biopharma..
01.11.202321:42EDGAR2Form 144 - Report of proposed sale of securities
01.11.202312:00GLOBEApplied Therapeutics to Host Diabetic Cardiomyopathy Expert..
31.10.202321:42EDGAR2Form 144 - Report of proposed sale of securities
13.10.202322:42EDGAR2Form 8-K - Current report
30.9.202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.9.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.9.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.9.202313:00GLOBEApplied Therapeutics to Present Baseline Data from Phase 3..
06.9.202317:08DJNApplied Therapeutics Shares Rise 11% After Pre-NDA Meeting..
06.9.202313:12EDGAR2Form 8-K - Current report
06.9.202313:00GLOBEApplied Therapeutics Announces Successful Pre-NDA Meeting..
11.8.202322:50EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock